C105P: Evolocumab Biosimilar, PCSK9 Monoclonal Antibody
Recombinant fully human IgG2 monoclonal antibody.
Specificity/Sensitivity: The monoclonal antibody evolocumab biosimilar specifically binds to the human PCSK9.
Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by evolocumab.PA001629-B0425: FADD (Ab-194) Polyclonal Antibody
Rabbit Polyclonal Antibody;
Applications: WB, IHC, ELISA;
Reactivity: Human.PA001629-C13053: FADD Polyclonal Antibody
Rabbit Polyclonal Antibody;
Applications: IHC, IF, ELISA;
Reactivity: Human.PA001629-PA1464: FADD Polyclonal Antibody
Rabbit Polyclonal Antibody;
Applications: WB;
Reactivity: Human;
Isotype: Rabbit IgG.BP002877-PRO-733: Recombinant Human Fas-Associated Death Domain (FADD) Protein
Source: E. coli-derived.
Purity: > 95.0% as determined by SDS-PAGE.BP005300: Human APRIL/TNFSF13 Trimer Protein with the N-His-Flag Tag
Source: The recombinant Human APRIL/TNFSF13 Trimer Protein, (amino acids Lys112-Leu250) fused with a His-Flag tag at the N-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human APRIL Trimer protein with the N-His-Flag tag at 0.2 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Human BCMAprotein with the N-hFc Tag with the EC50 of 3.4ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP005375: Human BAFF/TNFSF13B/CD257 Trimer Protein with the N-His-Flag Tag
Source: The recombinant Human BAFF/TNFSF13B/CD257 Trimer Protein, (amino acids Thr141-Leu285) fused with a His-Flag tag at the N-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human BAFF Trimer protein with the N-His-Flag tag at 1 ug/ml (100 ul/well). Dose response curve for the recombinant Human BAFFR protein with the N-hFc tag with the EC50 of 37.8 ng/ml determined by ELISA. The affinity constant of 6.59 nM as determined in SPR assay (Biacore T200).
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP005299: Human BAFF/TNFSF13B/CD257 Trimer Protein with the N-monomeric hFc-Flag Tag
Source: The recombinant Human BAFF/TNFSF13B/CD257 Trimer Protein, (amino acids Thr141-Leu285) fused with a monomeric hFc-Flag tag at the N-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human BAFF (Trimer) protein with the N-monomeric hFc-Flag tag at 5 ug/ml (100 ul/Well) on the plate. Dose response curve for the recombinant Human BAFFR protein with the N-His tag with the EC50 of 1.45 ug/ml determined by ELISA (QC Test). The affinity constant of 1.21 nM as determined in SPR assay (Biacore T200).
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP005307: Human BAFF/TNFSF13B/CD257 Protein with the N-monomeric hFc Tag
Source: The recombinant Human BAFF/TNFSF13B/CD257 Protein, (amino acids Ala134-Leu285) fused with a monomeric hFc tag at the N-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human BCMA Trimer protein with the N-monomeric hFc tag at 0.5 ug/ml (100 ul/Well) on the plate. Dose response curve for the recombinant Human BAFF protein with the N-hFc tag with the EC50 of 5.5 ng/ml determined by ELISA (QC Test). The affinity constant of 5.83 uM as determined in SPR assay (Biacore T200).
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.C011P: Infliximab Biosimilar, TNF alpha Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The monoclonal antibody Infliximab biosimilar specifically binds to the human TNF alpha.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by Infliximab.